Shandong Wit Dyne Health Co.,Ltd. (SHE:000915)

China · Delayed Price · Currency is CNY

26.20

+0.39 (1.51%)

Aug 20, 2026, 3:04 PM CST

-23.03% (1Y)

Market Cap	6.14B -23.0%
Revenue (ttm)	2.02B -7.1%
Net Income	463.31M -12.5%
EPS	1.97 -12.8%
Shares Out	234.33M
PE Ratio	13.29
Forward PE	n/a
Dividend	2.50 (9.69%)
Ex-Dividend Date	Jul 1, 2026

Volume	3,741,290
Open	25.94
Previous Close	25.81
Day's Range	25.85 - 26.25
52-Week Range	23.93 - 36.16
Beta	0.06
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About Shandong Wit Dyne Health

Shandong Wit Dyne Health Co.,Ltd. engages in the pharmaceutical business in China. Its medical products include azithromycin granules, glycyrrhizin zinc granules, compound calcium carbonate, vitamin AD drops, iprastat tablets, valsartan hydrochlorothiazide gel, roxithromycin, rosiglitazone tartrate tablets, and glimepiride tablets. The company also provides dextran iron granules, oral rehydration salts, montmorillonite powder, azithromycin granules, rifaximin dry suspension, and dimercaptosuccinic acid capsules. In addition, it offers informati... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1993

Employees 1,719

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 000915

Full Company Profile

Financial Performance

In 2025, Shandong Wit Dyne Health's revenue was 2.23 billion, an increase of 4.40% compared to the previous year's 2.13 billion. Earnings were 535.08 million, an increase of 3.78%.

Financial Statements